Hepatitis A, B, C and E virus markers in Chinese residing in Tokyo, Japan

Hepatology Research

Volumn 42, Issue 10, 2012, Pages 974-981

  Yan, Jun ^a,b   Kanda, Tatsuo ^a   Wu, Shuang ^a   Imazeki, Fumio ^a   Yokosuka, Osamu ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Kyowa Clinic   (Japan)

Author keywords

Chinese; HAV; HBV; HCV; HEV; Tokyo

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS A ANTIBODY; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BIRTHPLACE; BLOOD SAMPLING; CHINESE; CLINICAL PRACTICE; FAMILY HISTORY; FEMALE; HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS E VIRUS; HUMAN; HUMAN TISSUE; JAPAN; JAPANESE; LENGTH OF STAY; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; SERODIAGNOSIS; SEROPREVALENCE; THROMBOCYTE COUNT; VIRUS CARRIER;

EID: 84866761419     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01009.x     Document Type: Article

References (27)

1. Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA 2005; 294: 202-10.
2. Huang MA, Lok AS. Natural history of hepatitis B and outcomes after liver transplantation. Clin Liver Dis 2003; 7: 521-36.
3. Saito I, Miyamura T, Ohbayashi A etal. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A 1990; 87: 6547-9.
4. Kanda T, Yokosuka O, Imazeki F, Saisho H. Acute hepatitis C virus infection, 1986-2001: a rare cause of fulminant hepatitis in Chiba, Japan. Hepatogastroenterology 2004; 51: 556-8.
5. Tanaka J, Kumagai J, Katayama K etal. Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3, 485, 648 first-time blood donors during 1995-2000. Intervirology 2004; 47: 32-40.
6. FitzSimons D, Hendrickx G, Vorsters A, Damme PV. Hepatitis A and E: update on prevention and epidemiology. Vaccine 2010; 28: 583-8.
7. Sumi H, Yokosuka O, Seki N etal. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 2003; 37: 19-26.
8. Kanda T, Imazeki F, Yokosuka O. New antiviral therapies for chronic hepatitis C. Hepatol Int 2010; 19: 548-61.
9. Kanda T, Jeong SH, Imazeki F, Fujiwara K, Yokosuka O. Analysis of 5' nontranslated region of hepatitis A viral RNA genotype I from South Korea: comparison with disease severities. PLoS ONE 2010; 5: e15139.
10. Miyamura T, Ishii K, Kanda T etal. Possible widespread presence of hepatitis A subgenotype IIIA in Japan: recent trend of hepatitis A causing acute liver failure. Hepatol Res 2012; 42: 248-53.
11. Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 2010; 28: 6653-7.
12. Takeda H, Matsubayashi K, Sakata H etal. A nationwide survey for prevalence of hepatitis E virus antibody in qualified blood donors in Japan. Vox Sang 2010; 99: 307-13.
13. Lu J, Zhou Y, Lin X etal. General epidemiological parameters of viral hepatitis A, B, C, and E in six regions of China: a cross-sectional study in 2007. PLoS ONE 2009; 4: e8467.
14. The Ministry of Justice. [Cited 21 Dec 2011.] Available from URL: http://www.moj.go.jp/nyuukokukanri/kouhou/nyuukokukanri04_00005.html
15. Usuda S, Okamoto H, Iwanari H etal. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. J Virol Methods 1999; 80: 97-112.
16. Zhou YM, Yin ZF, Yang JM etal. Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China. World J Gastroenterol 2008; 14: 632-5.
17. Yuan Q, Ou SH, Chen CR etal. Molecular characteristics of occult hepatitis B virus from blood donors in southeast China. J Clin Microbiol 2010; 48: 357-62.
18. Chen SJ, Zhao YX, Fang Y etal. Viral deletions among healthy young Chinese adults with occult hepatitis B virus infection. Virus Res 2012; 163: 197-201.
19. Centers for Disease Control and Prevention (CDC). Progress in hepatitis B prevention through universal infant vaccination - China, 1997-2006. MMWR Morb Mortal Wkly Rep 2007; 56: 441-5.
20. Tanaka H, Imai Y, Hiramatsu N etal. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann Intern Med 2008; 148: 820-6.
21. Tamada Y, Yatsuhashi H, Masaki N etal. Hepatitis B virus strains of subgenotype A2 with an identical sequence spreading rapidly from the capital region to all over Japan in patients with acute hepatitis B. Gut 2011. Nov 7. [Epub ahead of print].
22. Koyama T, Matsuda I, Sato S, Yoshizawa H. Prevention of perinatal hepatitis B virus transmission by combined passive-active immunoprophylaxis in Iwate, Japan (1981-1992) and epidemiological evidence for its efficacy. Hepatol Res 2003; 26: 287-92.
23. Zhuang GH, Pan XJ, Wang XL. A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China. Vaccine 2008; 26: 4608-16.
24. Bian GL, Ma R, Dong HJ etal. Long-term clinical observation of the immunogenicity of inactivated hepatitis A vaccine in children. Vaccine 2010; 28: 4798-801.
25. Cao J, Wang Y, Song H etal. Hepatitis A outbreaks in China during 2006: application of molecular epidemiology. Hepatol Int 2009; 3: 356-63.
26. Takahashi M, Tamura K, Hoshino Y etal. A nationwide survey of hepatitis E virus infection in the general population of Japan. J Med Virol 2010; 82: 271-81.
27. Taniguchi M, Kim SR, Mishiro S etal. Epidemiology of hepatitis E in Northeastern China, South Korea and Japan. J Infect 2009; 58: 232-7.